The effect of 17 Β-estradiol on intracellular calcium homeostasis in human endothelial cells

European Journal of Pharmacology

Volumn 630, Issue 1-3, 2010, Pages 92-99

  Thor, Der ^a   Uchizono, James A ^a   Lin Cereghino, Geoff P ^a   Rahimian Roshanak, R ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Calcium; Endothelial nitric oxide synthase; Estrogen; Estrogen receptor alpha

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; THAPSIGARGIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CALCIUM; CELL LINE; ENDOTHELIAL CELLS; ESTRADIOL; ESTROGENS; HOMEOSTASIS; HUMANS;

EID: 77649191490     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.12.030     Document Type: Article

References (35)

1. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. JAMA 1991, 265:1861-1867.
2. Bryan R.M., You J., Golding E.M., Marrelli S.P. Endothelium-derived hyperpolarizing factor: a cousin to nitric oxide and prostacyclin. Anesthesiology 2005, 102:1261-1277.
3. 2+. Am. J. Physiol. Endocrinol. Metabol. 2009, 296:E503-E512.
4. Busse R., Edwards G., Feletou M., Fleming I., Vanhoutte P.M., Weston A.H. EDHF: bringing the concepts together. Trends Pharmacol. Sci. 2002, 23:374-380.
5. Deenadayalu V.P., White R.E., Stallone J.N., Gao X., Garcia A.J. Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H1720-H1727.
6. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:3734-3737.
7. Figtree G.A., McDonald D., Watkins H., Channon K.M. Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 2003, 107:120-126.
8. 2+ entry rather than altered receptor coupling. J. Endocrinol. 2006, 190:373-384.
9. 2+ channel function in uterine artery endothelial cells is associated with enhanced agonist-specific transient receptor potential channel 3-inositol 1, 4, 5-trisphosphate receptor 2 interaction. J. Endocrinol. 2006, 190:385-395.
10. Goetz R.M., Thatte H.S., Prabhakar P., Cho M.R., Michel T., Golan D.E. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2788-2793.
11. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B., Ernster V.L., Cummings S.R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 1992, 117:1016-1037.
12. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276:36869-36872.
13. Hayashi T., Fukuto J.M., Ignarro L.J., Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11259-11263.
14. Hayashi T., Yamada K., Esaki T., Kuzuya M., Satake S., Ishikawa T., Hidaka H., Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem. Biophys. Res. Commun. 1995, 214:847-855.
15. Herrington D.M., Reboussin D.M., Brosnihan K.B., Sharp P.C., Shumaker S.A., Snyder T.E., Furberg C.D., Kowalchuk G.J., Stuckey T.D., Rogers W.J., Givens D.H., Waters D. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N. Engl. J. Med. 2000, 343:522-529.
16. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998, 280:605-613.
17. Lantin-Hermoso R.L., Rosenfeld C.R., Yuhanna I.S., German Z., Chen Z., Shaul P.W. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am. J. Physiol. 1997, 273:L119-L126.
18. Muller, P.Y., Janovjak, H., Miserez, A.R., Dobbie, Z., 2002. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32, 1372-1374, 1376, 1378-1379.
19. Padar S., van Breemen C., Thomas D.W., Uchizono J.A., Livesey J.C., Rahimian R. Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its taxol-resistant subclone. Br. J. Pharmacol. 2004, 142:305-316.
20. Pollock J.S., Forstermann U., Mitchell J.A., Warner T.D., Schmidt H.H., Nakane M., Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:10480-10484.
21. Putney J.W. A model for receptor-regulated calcium entry. Cell Calcium 1986, 7:1-12.
22. Rahimian R., Chan L., Goel A., Poburko D., van Breemen C. Estrogen modulation of endothelium-derived relaxing factors by human endothelial cells. Biochem. Biophys. Res. Commun. 2004, 322:373-379.
23. Rahimian R., Dube G.P., Toma W., Dos Santos N., McManus B.M., van Breemen C. Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression. Eur. J. Pharmacol. 2002, 434:141-149.
24. Rahimian R., Laher I., Dube G., van Breemen C. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta. J. Pharmacol. Exp. Ther. 1997, 283:116-122.
25. Rahimian R., Van Breemen C., Karkan D., Dube G., Laher I. Estrogen augments cyclopiazonic acid-mediated, endothelium-dependent vasodilation. Eur. J. Pharmacol. 1997, 327:143-149.
26. 2+ concentration in rat valvular endothelial cells. Biochem. Biophys. Res. Commun. 1998, 248:916-919.
27. Reis S.E., Gloth S.T., Blumenthal R.S., Resar J.R., Zacur H.A., Gerstenblith G., Brinker J.A. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994, 89:52-60.
28. 2+ entry. Biochim. Biophys. Acta 2009, 1793:223-230.
29. Simon J.A., Hsia J., Cauley J.A., Richards C., Harris F., Fong J., Barrett-Connor E., Hulley S.B. Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-progestin Replacement Study (HERS). Circulation 2001, 103:638-642.
30. Stefano G.B., Prevot V., Beauvillain J.C., Cadet P., Fimiani C., Welters I., Fricchione G.L., Breton C., Lassalle P., Salzet M., Bilfinger T.V. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 2000, 101:1594-1597.
31. Stirone C., Chu Y., Sunday L., Duckles S.P., Krause D.N. 17 Beta-estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction. Eur. J. Pharmacol. 2003, 478:35-38.
32. 2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:2466-2470.
33. Toth B., Scholz C., Saadat G., Geller A., Schulze S., Mylonas I., Friese K., Jeschke U. Estrogen receptor modulators and estrogen receptor beta immunolabelling in human umbilical vein endothelial cells. Acta Histochem 1996, 111 (6):508-519.
34. Venkov C.D., Rankin A.B., Vaughan D.E. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996, 94:727-733.
35. White R.E. Estrogen and vascular function. Vasc. Pharmacol. 2002, 38:73-80.